Skip to main content
  • Pain Care

​CERUNIX EAR DROPS

COMPOSITION:

Each drop contains:
Paradichlorobenzene2% w/v
Benzocaine2.7% w/v
Chlorbutol5% w/v
Turpentine oil15% w/v

KEEP ALL MEDICINES OUT OF THE REACH OF CHILDREN.

Pharmacology
Pharmacodynamics: 
This combination ear drop solution contains the following active ingredients, each having a distinct role in relieving ear- related discomfort: 
∙Paradichlorobenzene (2.0%): A mild antiseptic and antifungal agent, used for its antimicrobial properties, particularly in preventing or treating ear infections. 
∙Benzocaine (2.7%): A local anaesthetic that provides pain relief by blocking nerve signals in the ear, making it useful for earache and discomfort. 
∙Chlorbutol (5.0%): An antiseptic and preservative that helps prevent bacterial growth and prolongs the shelf life of the solution. It has mild antifungal activity as well. 
∙Turpentine Oil (15.0%): A mild irritant with counterirritant and anti-inflammatory properties, helping to reduce swelling and relieve pain by promoting circulation in the ear area. 

Pharmacokinetics: 
∙Paradichlorobenzene is poorly absorbed systemically and acts locally in the ear. ∙Benzocaine is topically absorbed through the skin and mucous membranes, where it exerts its local anaesthetic effect. 
∙Chlorbutol is minimally absorbed through the skin and acts locally as an antiseptic. 
∙Turpentine Oil is absorbed through the skin, though it has limited systemic effects when used as an ear drop.
Indications
These ear drops are typically indicated for: 
  • Temporary relief of ear pain associated with ear infections, inflammation, or minor injuries. 
  • Prevention and treatment of ear infections caused by bacteria and fungi. 
  • Relief from itching and discomfort in the ear canal caused by minor irritations. 
  • Removal of earwax and softening of impacted earwax (though not a primary function).
Dosage
Adults: Use 2–3 drops twice daily for up to 3–4 days before attempting to clean the ear. 
Children (above 3 years): Use 2–3 drops twice daily for up to 3–4 days before attempting to clean the ear.

Administration Instructions 
  • Tilt the head sideways and instil the drops into the ear canal. 
  • Keep the head tilted for 2–3 minutes to allow absorption. 
  • Do not insert cotton swabs or objects into the ear after application.
Precautions
General Precautions: 
  • Do not use in cases of a perforated eardrum (hole in the eardrum), as it may lead to systemic absorption and further complications. 
  • Use with caution in individuals with sensitive skin or allergies to any of the ingredients. 
  • Avoid contact with the eyes, as the ingredients may cause irritation. 
  • If pain persists or ear discharge occurs, seek medical attention as it may indicate a more serious infection or condition. 

Warnings: 
  • Not for prolonged use: Extended use of ear drops may result in potential side effects, including irritation or allergic reactions. 
  • Turpentine oil may cause local irritation if used too frequently. 
  • Avoid using in combination with other ear products without consulting a healthcare provider. 

Contraindications: 
  • Perforated eardrum (e.g., due to trauma or infection) – may cause systemic absorption and harm. 
  • Hypersensitivity to any component of the ear drops (Paradichlorobenzene, Benzocaine, Chlorbutol, or Turpentine Oil). 
  • Active ear infection with drainage – avoid use until the ear is properly evaluated by a healthcare professional. 

Drug Interactions: 
  • No significant systemic drug interactions are expected when the drops are used as directed since the ingredients are locally acting. 
  • Caution is advised if using other topical products in or around the ear, especially those containing strong irritants or antiseptics. 
  • Avoid use with other local anaesthetics (such as lidocaine) to prevent excessive numbing or irritation in the ear.
Pregnancy
  • Pregnancy: The safety of this combination during pregnancy is not well-established. Use only if clearly needed, and consult a healthcare provider before use. 
  • Lactation: Benzocaine, Turpentine Oil, and Paradichlorobenzene are minimally absorbed systemically when applied topically, but consult a doctor before use, especially if breastfeeding.
Adverse Effects
Common Adverse Effects: 
  • Local irritation or mild burning sensation in the ear. 
  • Itching or redness around the ear or ear canal. 
  • Temporary numbness or tingling in the ear (due to Benzocaine). 

Serious Adverse Effects: 
  • Allergic reactions, including rash, swelling, or difficulty breathing (rare). 
  • Persistent pain, discharge, or worsening symptoms may indicate a more severe underlying condition such as an ear infection or perforated eardrum. 
Discontinue use and seek immediate medical attention if any serious reactions occur.
Overdosage
  • Overdose is unlikely with proper use, as the ear drops are applied locally and not absorbed in significant quantities. 
  • Symptoms of overdose could include excessive irritation or burning sensation in the ear, or severe allergic reactions if an individual is sensitive to any of the ingredients. 

Management of Overdose: 
  • If accidental ingestion or misuse occurs, seek immediate medical attention. 
  • Wash the ear thoroughly with warm water to remove excess product. 
  • Supportive treatment should be provided for any severe reactions, including antihistamines for allergic reactions.
Storage
  • Store the ear drops at room temperature (15–25°C). 
  • Keep the bottle tightly closed and out of reach of children. 
  • Avoid exposure to direct sunlight or extreme temperatures. 
  • Do not refrigerate or freeze the product. 
  • Check the expiry date and discard the product once it has expired.
Supply
10ml Pet Bottle

​RECOSPAS TABLET

COMPOSITION:

Each film coated tablet contains:
Aceclofenac IP100 mg
Paracetamol IP325 mg
Thiocolchicoside IP4 mg
Excipientsq.s.

KEEP ALL MEDICINES OUT OF THE REACH OF CHILDREN.

Pharmacology

Aceclofenac: 

A non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, leading to decreased prostaglandin synthesis. It reduces pain and inflammation. 


Paracetamol: An analgesic and antipyretic. It works primarily in the CNS, inhibiting COX enzymes and elevating the pain threshold. It has minimal anti-inflammatory activity. 


Thiocolchicoside: A muscle relaxant with anti-inflammatory and analgesic properties. It acts on the GABA-A receptors and glycine receptors in the CNS, helping reduce painful muscle spasms. INDICATIONS Recospas 


Tablet is indicated for the relief of: 

  • Acute painful musculoskeletal conditions 
  • Muscle spasms 
  • Back pain, neck pain, and other orthopaedic and post-traumatic pain states 
  • Pain associated with sprains, strains, and sports injuries
Indications

Recospas Tablet is indicated for the relief of: 

  • Acute painful musculoskeletal conditions 
  • Muscle spasms 
  • Back pain, neck pain, and other orthopaedic and post-traumatic pain states 
  • Pain associated with sprains, strains, and sports injuries
Dosage

Adults: One tablet twice daily after food or as directed by the physician. 

Not recommended for children below 18 years unless prescribed by a physician.

Precautions
General 
  • Use with caution in patients with hepatic or renal impairment. 
  • Avoid alcohol consumption due to increased risk of liver toxicity (due to Paracetamol). 
  • Monitor liver function if used for a prolonged period. 

Warnings 
  • Risk of gastrointestinal bleeding or ulceration (due to Aceclofenac). 
  • Can cause drowsiness (due to Thiocolchicoside); avoid operating machinery or driving. 
  • Caution in elderly patients as they are more sensitive to NSAIDs. 

Contraindications 
Hypersensitivity to any component of the formulation. 
Peptic ulcer disease or GI bleeding. 
Severe renal or hepatic impairment. 
Pregnancy and lactation (especially third trimester). 
Neurological disorders such as epilepsy (due to Thiocolchicoside’s potential convulsant effect). 

Drug Interaction 
With anticoagulants (e.g., warfarin): Increased risk of bleeding. 
With other NSAIDs or corticosteroids: Increased GI risk. 
With antiepileptics: Thiocolchicoside may lower seizure threshold. 
With alcohol: Increased hepatotoxicity risk. 
With methotrexate, lithium: Increased toxicity risk.
Pregnancy
  • Not recommended, especially in the third trimester. 
  • Thiocolchicoside has shown teratogenic effects in animal studies. 
  • Paracetamol is generally considered safe but not when combined with other agents unless advised by a physician.
Adverse Effects
  • Gastrointestinal: Nausea, vomiting, dyspepsia, diarrhoea, gastritis. 
  • Neurological: Drowsiness, dizziness. 
  • Hepatic: Elevated liver enzymes. 
  • Dermatologic: Rash, allergic reactions. 
  • Others: Renal dysfunction (rare), hypersensitivity reactions.
Overdosage
  • Paracetamol overdose can cause severe hepatotoxicity. 
  • Aceclofenac overdose may cause GI bleeding, renal dysfunction, CNS depression. 
  • Thiocolchicoside overdose may cause seizures.

Management 
  • Supportive and symptomatic treatment.
  • Gastric lavage if within 1 hour of ingestion. 
  • Activated charcoal if appropriate. 
  • N-acetylcysteine for paracetamol toxicity. 
  • Monitor liver and renal function closely
Storage
  • Store in a cool, dry place. 
  • Protect from direct sunlight and moisture. 
  • Keep out of reach of children.
Supply
Alu Alu 10 x 10’s Tablets

​SILOGESIC DT

COMPOSITION:

Each uncoated dispersible tablet contains:
Ketorolac Tromethamine I.P.10 mg
Excipientsq.s.

KEEP ALL MEDICINES OUT OF THE REACH OF CHILDREN.

Pharmacology

Ketorolac Tromethamine is a potent non-steroidal anti-inflammatory drug (NSAID) of the pyrrolo-pyrrole group. 

∙Mechanism of Action: Inhibits cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing prostaglandin synthesis involved in pain, inflammation, and fever. 


Pharmacokinetics 

∙Onset of Action: Within 30–60 minutes. 

∙Half-life: ~5–6 hours. 

∙Metabolism: Hepatic. ∙Excretion: Primarily renal.

Indications

Silogesic Tablet (Ketorolac 10 mg) is indicated for: 

Short-term management of moderate to severe acute pain, including:

  •  Postoperative pain 
  • Musculoskeletal pain 
  • Renal colic 
  • Dental pain 
  • Trauma or injury-related pain 


Note: It is not indicated for chronic pain or minor aches due to its strong GI and renal side effect profile.

Dosage

Adults (Oral): 

∙10 mg every 4–6 hours as needed. 

∙Maximum daily dose: 40 mg/day. 

∙Duration of use: Not more than 5 days (oral therapy), due to risk of adverse effects. 


Paediatric: Not recommended for children under 16 years unless prescribed.

Precautions
General 
  • Use the lowest effective dose for the shortest duration. 
  • Not intended for long-term or chronic pain treatment. 
  • Adequate hydration must be maintained to minimize renal risk.

 Warnings 
  • Increased risk of gastrointestinal bleeding, ulceration, or perforation, especially in elderly patients. 
  • Can cause renal impairment, particularly in volume-depleted patients. 
  • May elevate blood pressure and should be used cautiously in hypertensive patients. 
  • Can impair platelet aggregation and prolong bleeding time. 

Contraindications 
  • Hypersensitivity to ketorolac or other NSAIDs. 
  • Active peptic ulcer disease or recent GI bleeding/perforation. 
  • Renal impairment or dehydration. 
  • History of asthma, urticaria, or allergic-type reactions after taking NSAIDs. 
  • Concurrent use with aspirin or other NSAIDs. 
  • Perioperative pain management in CABG surgery. 
  • Pregnancy (third trimester) and lactation.

Drug Interaction 
  • Anticoagulants/Antiplatelets: Increased risk of bleeding. 
  • ACE inhibitors/ARBs/Diuretics: Increased risk of nephrotoxicity. 
  • Lithium: Increased serum lithium levels and toxicity. 
  • Methotrexate: Enhanced toxicity. 
  • SSRIs/SNRIs: Increased risk of GI bleeding.
Pregnancy
  • Category C (first and second trimester), Category D (third trimester). 
  • Contraindicated in third trimester due to risk of premature closure of the ductus arteriosus and prolonged labour. 
  • Avoid in breastfeeding unless benefit outweighs risk.
Adverse Effects
  • Common: Nausea, abdominal pain, dyspepsia, headache, dizziness. 
  • Serious: GI bleeding, peptic ulceration, renal dysfunction, hypertension, hypersensitivity reactions, bronchospasm.
Overdosage
Symptoms of Overdose 
  • Nausea, vomiting, abdominal pain, GI bleeding, drowsiness, renal failure, metabolic acidosis. 

Management 
  • Supportive and symptomatic treatment. 
  • Activated charcoal if within 1 hour of ingestion. 
  • Monitor renal and hepatic function, and blood counts. 
  • No specific antidote available.
Storage
  • Store below 25°C in a cool, dry place. 
  • Protect from light and moisture. 
  • Keep out of reach of children
Supply
Alu Alu 10 x 15 Tablets

​​​TYMOLYTIC AP TABLET 

COMPOSITION:

Each film coated tablet contains:
Aceclofenac IP100 mg
Paracetamol IP325 mg
50000 Armour units of enzymatic activity
(supplied by a purified concentrate which has specific Trypsin Chymotrypsin activity in a ratio of approximately 6:1)
Excipientsq.s.

KEEP ALL MEDICINES OUT OF THE REACH OF CHILDREN.

Pharmacology

Trypsin + Chymotrypsin (Proteolytic Enzyme Complex) 

∙Derived from pancreatic enzymes, these proteolytic enzymes enhance tissue repair by breaking down fibrin, proteins, and inflammatory debris. 

∙Anti-inflammatory by reducing edema and inflammation at injury sites. 

∙Trypsin and Chymotrypsin together increase microcirculation and support healing. 


Aceclofenac 

∙A non-steroidal anti-inflammatory drug (NSAID). 

∙Inhibits cyclooxygenase (COX-2 > COX-1), thereby reducing prostaglandin synthesis. 

∙Provides analgesic, anti-inflammatory, and antipyretic effects. 


Paracetamol (Acetaminophen) 

∙A centrally acting analgesic and antipyretic. 

∙Inhibits prostaglandin synthesis in CNS. 

∙Less anti-inflammatory activity than NSAIDs, but excellent for pain and fever. 


Synergy: 

∙Aceclofenac + Paracetamol relieve pain, inflammation, and fever, 

∙Trypsin-Chymotrypsin accelerates healing and edema reduction.

Indications

Tymolytic AP is indicated for:

  • Postoperative inflammation and pain 
  • Musculoskeletal pain (sprains, strains, tendonitis) 
  • Orthopaedic trauma or sports injuries 
  • Dental surgeries and infections ENT surgeries (tonsillectomy, sinusitis-related edema) 
  • Soft tissue inflammation, hematomas, and contusions 
  • Osteoarthritis, spondylitis, and rheumatic conditions
 
Dosage

Adults: 

1 tablet twice daily, preferably 1 hour before meals or as advised by a physician 

Adjust dose based on clinical condition and physician recommendation. 


Children: 

Not typically recommended. Use under medical supervision only.

Precautions
General 
  • Use with caution in elderly, renal impairment, or dehydrated individuals. 
  • Not recommended for long-term use without medical supervision. 

Warnings 
  • May cause gastrointestinal irritation, especially with prolonged use. 
  • Use cautiously in hypertensive or cardiac patients due to fluid retention risk (NSAID component). 
  • Liver enzyme monitoring is advised for long-term use due to paracetamol. 

Contraindications 
  • Hypersensitivity to any of the ingredients. 
  • Active or history of gastric ulcers or GI bleeding. 
  • Severe hepatic or renal impairment. 
  • Bleeding disorders (due to proteolytic enzymes). 
  • Pregnancy (3rd trimester) due to NSAID component. 

Drug Interaction 
  • Anticoagulants (e.g., warfarin) – Increased bleeding risk. 
  • Methotrexate, lithium – Enhanced toxicity. 
  • Alcohol – Increased hepatotoxicity with paracetamol. 
  • Other NSAIDs or corticosteroids – Additive GI toxicity. 
  • CE inhibitors/Diuretics – Reduced efficacy, increased renal risk.
Pregnancy
  • Avoid in 3rd trimester due to potential for premature ductus arteriosus closure (NSAIDs). 
  • Use in 1st and 2nd trimester only if clearly necessary. 
  • Not recommended during lactation unless benefits outweigh risk.
Adverse Effects
  • Gastrointestinal: Nausea, dyspepsia, epigastric pain, ulcers. 
  • Renal: Elevated serum creatinine, reduced GFR (rare). 
  • Hepatic: Elevated liver enzymes (with paracetamol). 
  • Allergic: Rash, itching, rarely angioedema or anaphylaxis. 
  • Enzymes: Mild nausea, altered taste, rarely allergic reactions.
Overdosage
  • Aceclofenac: GI bleeding, renal damage. 
  • Paracetamol: Hepatotoxicity, especially >4 g/day. 
  • Trypsin-Chymotrypsin: Generally safe, but may cause nausea or GI upset in excess. 

Management 
  • Symptomatic support. 
  • For paracetamol overdose: N-Acetylcysteine (NAC) is the antidote. 
  • Monitor LFTs, renal function, and electrolytes.
Storage
  • Store at 15–25°C in a cool, dry place. 
  • Protect from light and moisture. 
  • Keep out of reach of children.
Supply
Alu-Alu 10 x10’s Tablets

​TYMOLYTIC PLUS TABLET 

COMPOSITION:

Each enteric coated tablet contains:
50000 Armour units of enzymatic activity
(supplied by a purified concentration which has specific Trypsin and Chymotrypsin activity in a ratio of approximately 6:1)
Diclofenac Potassium IP50 mg
Excipientsq.s.

KEEP ALL MEDICINES OUT OF THE REACH OF CHILDREN.

Pharmacology

Trypsin + Chymotrypsin (6:1) 

∙Proteolytic enzymes derived from the pancreas. 

∙Work by breaking down inflammatory proteins and fibrin, reducing swelling, edema, and enhancing microcirculation at the inflammation site. 

∙Improve wound healing, resolve post-traumatic and surgical edema, and support tissue regeneration. 


Diclofenac Potassium 

∙A fast-acting NSAID with analgesic, antipyretic, and anti-inflammatory effects. 

∙Inhibits cyclooxygenase (COX-1 and COX-2), decreasing prostaglandin synthesis which reduces inflammation and pain. 

∙Potassium salt form ensures rapid absorption and onset of action. 


Synergy: 

Diclofenac provides quick pain relief, while Trypsin-Chymotrypsin supports tissue repair and swelling reduction, making it ideal for injury and post-op recovery.

Indications

Tymolytic Plus is indicated for: 

∙Episiotomy 

∙Musculoskeletal injuries (sprains, strains, contusions) 

∙Postoperative inflammation and edema 

∙Orthopaedic trauma and joint pain 

∙Arthritis, spondylitis, bursitis, and tendinitis 

∙ENT surgeries, sinusitis, and soft tissue inflammation 

∙Sports injuries and inflammatory swelling


Dosage

Adults: 

1 tablet twice daily, preferably 1 hour before meals or as advised by a physician. 

Children:

Not recommended unless prescribed by a healthcare professional.

Precautions
General 
  • Use with caution in elderly, renal impairment, or gastric ulcer history. 
  • Ensure adequate hydration during treatment.

 Warnings 
  • Long-term use may lead to GI, hepatic, or renal side effects. 
  • Avoid alcohol during therapy due to enhanced GI and liver risks. 
  • May mask symptoms of infection; use cautiously in infected patients. 

Contraindications 
  • Hypersensitivity to diclofenac, proteolytic enzymes, or excipients. 
  • Active peptic ulcer, GI bleeding, or perforation history. 
  • Severe hepatic, renal, or cardiac impairment. 
  • Known bleeding disorders. ∙Asthma, urticaria, or allergic reaction triggered by NSAIDs. 

Drug Interaction 
  • Anticoagulants (e.g., warfarin) – Increased risk of bleeding. 
  • Other NSAIDs or corticosteroids – Enhanced GI toxicity. 
  • Diuretics, ACE inhibitors – Increased renal risk. 
  • Methotrexate, lithium – Enhanced toxicity. 
  • Antibiotics (e.g., amoxicillin) – Absorption may be enhanced by bromelain.
Pregnancy
  • Not recommended in the 3rd trimester – risk of premature ductus arteriosus closure. 
  • Use with caution in 1st and 2nd trimesters if benefits outweigh risks. 
  • Avoid in lactating women, unless prescribed.
Adverse Effects
  • GI: Nausea, vomiting, abdominal pain, dyspepsia, ulcers, bleeding. 
  • Hepatic: Elevated liver enzymes. 
  • Renal: Nephrotoxicity (rare). 
  • CNS: Headache, dizziness. 
  • Hypersensitivity: Rash, itching, urticaria. 
  • Enzymatic: Rare GI upset, altered taste, allergic reactions.
Overdosage
Symptoms: 
  • Diclofenac: GI bleeding, renal failure, hypotension, CNS depression. 
  • Trypsin-Chymotrypsin: Generally well-tolerated; may cause GI upset in high doses. 

Management: 
  • Supportive and symptomatic treatment. 
  • Monitor liver and renal function. 
  • Gastric lavage and activated charcoal if early.
Storage
  • Store in a cool, dry place below 25°C. 
  • Protect from light and moisture. 
  • Keep out of reach of children.
Supply
Alu-Alu 10 x10’s Tablets

​TYMOLYTIC NANOGEL

COMPOSITION:

Each gm contains:
Diclofenac Diethylamine IP4.64% w/v
(equivalent to Diclofenac Sodium)4.00% w/v
In Methyl Salicylate Gel Base

KEEP ALL MEDICINES OUT OF THE REACH OF CHILDREN.

Pharmacology
Diclofenac Diethylamine: 
∙A non-steroidal anti-inflammatory drug (NSAID). 
∙Acts by inhibiting cyclooxygenase (COX-1 and COX-2), blocking prostaglandin synthesis involved in pain and inflammation. 
∙In topical form, it penetrates the skin locally to reduce pain and inflammation without significant systemic absorption. 

Methyl Salicylate: 
∙A counterirritant that causes vasodilation and produces a warming effect, distracting from deeper pain signals. 
∙Enhances skin permeability of Diclofenac for better action. 

Nano Technology Benefit: 
∙Smaller particle size enhances skin penetration and bioavailability. 
∙Enables faster onset of action and prolonged retention in affected tissues. 
∙Reduces greasiness and improves patient compliance. 

Combined Effect: 
Fast topical relief of muscle and joint pain, inflammation, and stiffness.
Indications
Tymolytic Nanogel is indicated for:
  •  Musculoskeletal pain (sprains, strains, and sports injuries) 
  • Arthritis (osteoarthritis, rheumatoid arthritis) 
  • Backache, neck pain, shoulder stiffness 
  • Tendinitis, bursitis, myositis 
  • Soft tissue injuries and localized inflammation
Dosage
  • Apply a small quantity (2–4 g) to the affected area 3–4 times daily. 
  • Gently massage until fully absorbed. 
  • Do not use on broken or irritated skin. 
  • Wash hands after application unless hands are the treated area. 
Precautions
General 
  • For external use only. 
  • Avoid contact with eyes, mucous membranes, or open wounds. 
  • Do not apply with occlusive bandages or heat packs. 

Warnings 
  • Prolonged use may lead to local irritation. 
  • Do not use on infected skin lesions or eczema. 
  • if irritation or allergic reaction occurs, discontinue use. 

Contraindications 
  • Hypersensitivity to diclofenac, salicylates, or other NSAIDs. 
  • Broken or inflamed skin. ∙
  • Third trimester of pregnancy.

 Drug Interaction
  • Minimal systemic absorption — low potential for interactions. 
  • Avoid use with other topical NSAIDs or salicylates to prevent cumulative irritation.
Pregnancy
  • Avoid during third trimester due to risk of premature ductus arteriosus closure. 
  • Use in first and second trimesters only if clearly needed. 
  • Avoid during lactation on or near the chest area.
Adverse Effects
  • Local: Rash, redness, pruritus, burning sensation. 
  • Systemic (rare): Headache, nausea, dizziness (with overuse or prolonged use).
Overdosage
  • Topical overdose is rare. 
  • Symptoms: Local irritation, redness, or rash. 
  • Management: Wash area thoroughly with soap and water. Symptomatic care.
Storage
  • Store in a cool, dry place below 25°C. 
  • Protect from light and moisture. 
  • Keep out of reach of children.
Supply
20gm Lame Tube

​TURINSE GARGLE

COMPOSITION:

Each 5 mL contains:
Benzydamine Hydrochloride BP7.5 mg
Chlorhexidine Gluconate Solution IP
eq. to Chlorhexidine Gluconate6.0 mg
In pleasant flavoured aqueous baseq.s.

KEEP ALL MEDICINES OUT OF THE REACH OF CHILDREN.

Pharmacology
Benzydamine Hydrochloride (7.5 mg) 
∙A non-steroidal anti-inflammatory drug (NSAID) used topically for analgesic, anti-inflammatory, and local anaesthetic effects. 
∙Mechanism: Inhibits pro-inflammatory cytokines and stabilizes cell membranes, leading to reduced inflammation and pain in the oral cavity. 
∙Provides rapid local relief with minimal systemic absorption. 

Chlorhexidine Gluconate (6 mg) 
∙A broad-spectrum antiseptic and antimicrobial agent. 
∙Acts by disrupting bacterial cell membranes, leading to cell lysis. 
∙Effective against Gram-positive and Gram-negative bacteria, fungi, and some viruses. 
∙Long-lasting antibacterial effect due to substantivity (binding to oral tissues). 

Combination Advantage: 
∙Benzydamine provides pain relief and inflammation control, while 
∙Chlorhexidine provides antiseptic protection, reducing infection and promoting healing.​ Ideal for post-surgical oral care and painful throat/mouth conditions.
Indications
Turinse Mouthwash is indicated for: 
∙Sore throat and pharyngitis 
∙Tonsillitis 
∙Oral mucositis (especially in cancer patients) 
∙Post-tonsillectomy or dental surgery pain relief and antisepsis 
∙Mouth ulcers (aphthous ulcers) 
∙Gingivitis, periodontitis and stomatitis 
∙General throat hygiene in infection-prone individuals.
Dosage
Adults and children over 12 years: 
∙Gargle or rinse with 15 ml (undiluted or as directed) for 30–60 seconds, 2–3 times daily. 
∙Spit out after gargling; Do not swallow. 
∙Avoid food and drink for 15–30 minutes after use. 

Children <12 years: Use under medical supervision.
Precautions
General 
  • Do not swallow the solution. 
  • Rinse mouth and gargle thoroughly to ensure full contact with the affected areas. 
  • Avoid using immediately after brushing with SLS-containing toothpaste (wait at least 30 minutes). 

Warnings 
  • May cause oral numbness or stinging (due to Benzydamine). 
  • Tooth/tongue staining and altered taste may occur with prolonged use (due to chlorhexidine). 
  • Discontinue use if irritation, swelling, or allergy develops. 

Contraindications 
  • Known hypersensitivity to benzydamine, chlorhexidine, or any excipients. 
  • History of allergic reactions to other local antiseptics or NSAIDs. 

Drug Interaction 
  • Toothpaste (especially SLS-based) may inactivate chlorhexidine—use the gargle at a different time. 
  • Avoid concurrent use with other cationic antiseptics unless advised.
Pregnancy
  • Benzydamine: Category B 
  • Chlorhexidine: Generally considered safe topically 
  • Can be used during pregnancy and breastfeeding under medical supervision; avoid prolonged use.
Adverse Effects
  • Common: Mild burning, dry mouth, oral numbness, taste alteration. 
  • Less common: Tooth discoloration, tongue staining. 
  • Rare: Allergic reactions, including rash, swelling, or difficulty breathing.
Overdosage
∙Unlikely with topical use. 
∙Ingestion in large quantities may cause:
  •  Nausea, vomiting, gastric irritation. 
  • CNS symptoms (very rare) like restlessness or drowsiness. 
∙Management: Symptomatic and supportive. Seek medical attention in case of significant ingestion.
Storage
  • Store at 15–25°C in a cool, dry place. 
  • Protect from direct sunlight and heat. 
  • Do not freeze. 
  • Keep tightly closed and out of reach of children.
Supply
150ml Pet Bottle

​ULTRANEX DT 

COMPOSITION:

Each uncoated dispersible tablet contains:
Piroxicam I.P.20 mg
Excipientsq.s.

KEEP ALL MEDICINES OUT OF THE REACH OF CHILDREN.

Pharmacology
Pharmacodynamics 
Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, reducing the synthesis of prostaglandins, which are responsible for inflammation, pain, and fever. It has analgesic, anti-inflammatory, and antipyretic properties. 

Pharmacokinetics 
  • Absorption: Rapidly absorbed from the gastrointestinal tract. Peak plasma concentration is reached in 3–5 hours. 
  • Distribution: Highly protein-bound (~99%). 
  • Metabolism: Metabolized in the liver, primarily via CYP2C9 enzyme. 
  • Elimination: Excreted mainly through the urine and faeces with a half-life of ~50 hours, allowing for once-daily dosing.
Indications
  • Piroxicam 20mg Dispersible Tablets are indicated for: 
  • Osteoarthritis (joint pain and stiffness) 
  • Rheumatoid arthritis (joint inflammation and damage) 
  • Ankylosing spondylitis (spinal arthritis) 
  • Acute musculoskeletal disorders (e.g., sprains, strains) 
  • Postoperative pain management
Dosage

Adults: Osteoarthritis & Rheumatoid Arthritis: 20 mg once daily or 10 mg twice daily Acute Musculoskeletal Disorders & Postoperative Pain: 40 mg once daily for 2 days, then reduce to 20 mg daily for a short duration 
Elderly Patient: Start with the lowest effective dose (10 mg once daily) to reduce the risk of side effects. 
Children: Not recommended due to safety concerns.
Precautions

General 

  • Use the lowest effective dose for the shortest duration to minimize side effects.
  • Increases the risk of gastrointestinal (GI) ulcers, bleeding, and perforation, especially in elderly patients.
  • May cause fluid retention and worsen heart failure or hypertension. 
  • Long-term use is associated with renal toxicity—monitor kidney function regularly.

Warnings 

  • GI Risk: May cause ulcers, bleeding, or perforation, especially in the elderly. 
  • Cardiovascular Risk: Increases risk of heart attack and stroke; avoid in CVD patients. 
  • Kidney Toxicity: Can cause renal failure, especially in those with CKD. 
  • Liver Damage: May lead to hepatitis or liver failure. 
  • Blood Disorders: Can cause anemia, bleeding, or thrombocytopenia. 
  • Fluid Retention & Hypertension: Worsens heart failure and high blood pressure. 
  • Allergic Reactions: Risk of anaphylaxis, Stevens-Johnson syndrome (SJS). 
  • Fertility Issues: May impair female ovulation.

Contraindications 

  • Allergy to NSAIDs or Piroxicam 
  • Active peptic ulcer or GI bleeding 
  • Severe heart disease (recent heart attack, stroke, heart failure) 
  • Severe kidney or liver impairment 
  • Bleeding disorders or anticoagulant use ∙Pregnancy (third trimester) 
  • Children under 12 years

Drug Interaction

  • Anticoagulants (Warfarin, Heparin) - Increased bleeding risk - Monitor INR/bleeding signs 

    Antihypertensives (ACE inhibitors, ARBs, Beta-blockers) - Reduced effectiveness - Monitor BP 

    Diuretics (Furosemide, Thiazides) - Reduced diuretic effect - Monitor kidney function 

    Corticosteroids (Prednisolone, Dexamethasone) - Increased GI ulcer risk - Use gastroprotective agents 

    Methotrexate - Increased toxicity risk - Monitor blood levels 

    Lithium - Increased lithium toxicity - Monitor lithium levels 

Pregnancy
  • Category C (1st & 2nd trimester): Use only if benefits outweigh risks. 
  • Category D (3rd trimester): Contraindicated due to risk of premature closure of ductus arteriosus, delayed labor, and neonatal complications. 
  • Avoid use during breastfeeding as it may pass into breast milk.
Adverse Effects
Gastrointestinal (GI) - Nausea, indigestion, diarrhea - Peptic ulcer, GI bleeding, perforation 

Cardiovascular - Hypertension, edema - Heart attack, stroke 

Renal - Fluid retention, mild renal impairment - Acute kidney failure 

Hepatic - Elevated liver enzymes - Hepatitis, liver failure 

Neurological - Dizziness, headache - Seizures, aseptic meningitis 

Hematological - Mild anemia - Thrombocytopenia, agranulocytosis 
Overdosage

Symptoms of Overdose 

  • Severe nausea, vomiting, and stomach pain 
  • Drowsiness, confusion, dizziness 
  • Severe GI bleeding (black stools, vomiting blood) 
  • Seizures, respiratory depression, kidney failure 

Management 

  • No specific antidote—treatment is symptomatic and supportive. 
  • Gastric lavage & activated charcoal may help if ingestion was recent. 
  • Proton pump inhibitors (PPIs) or H2 blockers to protect the stomach. 
  • IV fluids and electrolyte correction for dehydration. 
  • Haemodialysis is NOT effective due to high protein binding.
Storage
  • Store at room temperature (15–30°C), away from moisture and heat. 
  • Keep the tablets in their original packaging. 
  • Protect from direct sunlight. 
  • Keep out of reach of children. 
  • Do not use beyond the expiry date printed on the package.
Supply

Alu Alu 10 x 15 Tablets